Literature DB >> 3227644

Nucleotide sequence of dengue type 3 virus genomic RNA encoding viral structural proteins.

K Osatomi1, I Fuke, D Tsuru, T Shiba, Y Sakaki, H Sumiyoshi.   

Abstract

Complementary DNAs to the 5' proximal region of the dengue virus type 3 RNA were cloned into bacterial plasmids and the nucleotide sequence of 3,000 bases from the 5' terminus of the genome were determined by DNA and RNA sequencing methods using dideoxy chain-termination reactions. Comparison of the nucleotide sequence thus obtained with those of other flavivirus genomes revealed significant homology existing in nucleotide sequence of the flavivirus genomes. When we compared amino acid sequence deduced from the nucleotide sequence with those of other flaviviruses, this genome region was found to include sequences encoding three viral structural proteins C, M, and E and a part of the viral nonstructural protein NS1 in this order in addition to the 5'-noncoding sequence. The characteristics and functions of these proteins were discussed based on the deduced amino acid sequences and their hydrophobic profiles. The genetic relationship of flaviviruses was also discussed based on the genetic variation observed in their genomes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3227644     DOI: 10.1007/bf00569739

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  11 in total

1.  Genetic characterization of newly reintroduced dengue virus type 3 in Martinique (French West Indies).

Authors:  Christophe N Peyrefitte; Patricia Couissinier-Paris; Véronique Mercier-Perennec; Maël Bessaud; Jenny Martial; Nadia Kenane; Jean-Paul A Durand; Hugues J Tolou
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 2.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

3.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Dengue viral infections.

Authors:  Padmalal Gurugama; Pankaj Garg; Jennifer Perera; Ananda Wijewickrama; Suranjith L Seneviratne
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

5.  A rapid method for detection and identification of flaviviruses by polymerase chain reaction and nucleic acid hybridization.

Authors:  B Puri; E A Henchal; J Burans; K R Porter; W Nelson; D M Watts; C G Hayes
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Authors:  David E Clements; Beth-Ann G Coller; Michael M Lieberman; Steven Ogata; Gordon Wang; Kent E Harada; J Robert Putnak; John M Ivy; Michael McDonell; Gary S Bignami; Iain D Peters; Julia Leung; Carolyn Weeks-Levy; Eileen T Nakano; Tom Humphreys
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

7.  Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice.

Authors:  R H Men; M Bray; C J Lai
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus.

Authors:  G J Chang; B C Cropp; R M Kinney; D W Trent; D J Gubler
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Dengue type 3 virus, Saint Martin, 2003-2004.

Authors:  Christophe N Peyrefitte; Boris A M Pastorino; Maël Bessaud; Patrick Gravier; Fabienne Tock; Patricia Couissinier-Paris; Jenny Martial; Patricia Huc-Anais; Raymond Césaire; Marc Grandadam; Hugues J Tolou
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

Review 10.  Anti-dengue Vaccines: From Development to Clinical Trials.

Authors:  Josilene Ramos Pinheiro-Michelsen; Rayane da Silva Oliveira Souza; Itana Vivian Rocha Santana; Patrícia de Souza da Silva; Erick Carvalho Mendez; Wilson Barros Luiz; Jaime Henrique Amorim
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.